This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ea Pharma Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Daisuke Kataoka: Innovator in Medicinal Composition
Introduction
Daisuke Kataoka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of secondary hyperparathyroidism. His innovative approach has led to the development of a unique medicinal composition that addresses a critical health issue for patients undergoing maintenance dialysis.
Latest Patents
Kataoka holds a patent for a medicinal composition aimed at preventing or treating secondary hyperparathyroidism under maintenance dialysis. This composition includes 3-{[(2S)-2-amino-2-carboxyethyl]carbamoylamino}-5-chloro-4-methylbenzenesulfonic acid or a pharmaceutically acceptable salt thereof. The invention is designed to be administered through a predefined route and dosage, providing a prophylactic or therapeutic agent that exhibits reduced side effects and minimal accumulation in the body. This innovative medicinal agent allows for easier management of administration and offers a higher safety profile compared to conventional treatments.
Career Highlights
Daisuke Kataoka has established himself as a key figure in the pharmaceutical industry. His work at Ea Pharma Co., Ltd. has been instrumental in advancing therapeutic options for patients with specific medical needs. His dedication to research and development has resulted in impactful innovations that enhance patient care.
Collaborations
Kataoka has collaborated with notable colleagues, including Kazuo Kuyama and Kenji Asano. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.
Conclusion
Daisuke Kataoka's contributions to medicinal chemistry exemplify the importance of innovation in healthcare. His patented composition for treating secondary hyperparathyroidism represents a significant advancement in patient treatment options. Through his work, he continues to make a positive impact on the lives of patients undergoing maintenance dialysis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile